Table 1:

Key inclusion and exclusion criteria

Inclusion criteriaExclusion criteria
Thoracic aortic aneurysm >50 mm wide<20 years old
Aneurysm enlarged by ≥5 mm in <12 monthsPregnancy
Saccular aneurysm >10 mm in the maximum transverse directionEstimated life expectancy <12 months
Failure to indicate their intention to participate
New York Heart Association Class IV
Myocardial infarction within previous 3 months
Cerebral vascular accident with previous 3 months
Connective tissue disease (e.g. Marfans and Ehlers-Danlos syndrome)
History of bleeding diathesis (including a DIC score > 6, caused by aneurysm, without palliative therapy), coagulopathy or refusal to get blood transfusions
Sensitivity or allergy to stainless steel, ePTFE, PVDF, contrast media or heparin
Unclear cerebellar arteries or Circle of Willis, requiring a stent-graft repair of the sub-clavian artery but without prior bilateral sub-clavian artery bypass
No planned blockage of the LSA, with a <10-mm proximal LZ from the LSA to the aneurysm
No planned blockage of the left carotid artery, with a <10-mm proximal LZ from the left carotid artery to the aneurysm
No planned blockage of the brachiocephalic trunk, with <10 mm proximal LZ from the brachiocephalic trunk to the aneurysm
Planned blockage of the celiac trunk, with an unclear connection between the SMA to the celiac trunk via the pancreaticoduodenal arcade
Planned blockage of the celiac trunk, with a <15-mm proximal LZ from the SMA to the aneurysm
No planned blockage of the celiac trunk, with a <15-mm proximal LZ from the celiac trunk to the aneurysm
Unfavourable access route with calcification, stenosis and tortuous iliac
Unfavourable LZ with calcification, mural haematoma and atheroma
Significant formation of atheroma in the access route, with risk of atherothrombosis
Thoracic aneurysm with a contained rupture
Aortic diameter of <18 or >43 mm in the proximal LZ
Active systemic infection
Inclusion criteriaExclusion criteria
Thoracic aortic aneurysm >50 mm wide<20 years old
Aneurysm enlarged by ≥5 mm in <12 monthsPregnancy
Saccular aneurysm >10 mm in the maximum transverse directionEstimated life expectancy <12 months
Failure to indicate their intention to participate
New York Heart Association Class IV
Myocardial infarction within previous 3 months
Cerebral vascular accident with previous 3 months
Connective tissue disease (e.g. Marfans and Ehlers-Danlos syndrome)
History of bleeding diathesis (including a DIC score > 6, caused by aneurysm, without palliative therapy), coagulopathy or refusal to get blood transfusions
Sensitivity or allergy to stainless steel, ePTFE, PVDF, contrast media or heparin
Unclear cerebellar arteries or Circle of Willis, requiring a stent-graft repair of the sub-clavian artery but without prior bilateral sub-clavian artery bypass
No planned blockage of the LSA, with a <10-mm proximal LZ from the LSA to the aneurysm
No planned blockage of the left carotid artery, with a <10-mm proximal LZ from the left carotid artery to the aneurysm
No planned blockage of the brachiocephalic trunk, with <10 mm proximal LZ from the brachiocephalic trunk to the aneurysm
Planned blockage of the celiac trunk, with an unclear connection between the SMA to the celiac trunk via the pancreaticoduodenal arcade
Planned blockage of the celiac trunk, with a <15-mm proximal LZ from the SMA to the aneurysm
No planned blockage of the celiac trunk, with a <15-mm proximal LZ from the celiac trunk to the aneurysm
Unfavourable access route with calcification, stenosis and tortuous iliac
Unfavourable LZ with calcification, mural haematoma and atheroma
Significant formation of atheroma in the access route, with risk of atherothrombosis
Thoracic aneurysm with a contained rupture
Aortic diameter of <18 or >43 mm in the proximal LZ
Active systemic infection

LZ: landing zone; SMA: superior mesenteric artery; DIC: disseminated intravascular coagulation; ePTFE: expanded polytetrafluoroethylene; PVDF: polyvinylidene fluoride.

Table 1:

Key inclusion and exclusion criteria

Inclusion criteriaExclusion criteria
Thoracic aortic aneurysm >50 mm wide<20 years old
Aneurysm enlarged by ≥5 mm in <12 monthsPregnancy
Saccular aneurysm >10 mm in the maximum transverse directionEstimated life expectancy <12 months
Failure to indicate their intention to participate
New York Heart Association Class IV
Myocardial infarction within previous 3 months
Cerebral vascular accident with previous 3 months
Connective tissue disease (e.g. Marfans and Ehlers-Danlos syndrome)
History of bleeding diathesis (including a DIC score > 6, caused by aneurysm, without palliative therapy), coagulopathy or refusal to get blood transfusions
Sensitivity or allergy to stainless steel, ePTFE, PVDF, contrast media or heparin
Unclear cerebellar arteries or Circle of Willis, requiring a stent-graft repair of the sub-clavian artery but without prior bilateral sub-clavian artery bypass
No planned blockage of the LSA, with a <10-mm proximal LZ from the LSA to the aneurysm
No planned blockage of the left carotid artery, with a <10-mm proximal LZ from the left carotid artery to the aneurysm
No planned blockage of the brachiocephalic trunk, with <10 mm proximal LZ from the brachiocephalic trunk to the aneurysm
Planned blockage of the celiac trunk, with an unclear connection between the SMA to the celiac trunk via the pancreaticoduodenal arcade
Planned blockage of the celiac trunk, with a <15-mm proximal LZ from the SMA to the aneurysm
No planned blockage of the celiac trunk, with a <15-mm proximal LZ from the celiac trunk to the aneurysm
Unfavourable access route with calcification, stenosis and tortuous iliac
Unfavourable LZ with calcification, mural haematoma and atheroma
Significant formation of atheroma in the access route, with risk of atherothrombosis
Thoracic aneurysm with a contained rupture
Aortic diameter of <18 or >43 mm in the proximal LZ
Active systemic infection
Inclusion criteriaExclusion criteria
Thoracic aortic aneurysm >50 mm wide<20 years old
Aneurysm enlarged by ≥5 mm in <12 monthsPregnancy
Saccular aneurysm >10 mm in the maximum transverse directionEstimated life expectancy <12 months
Failure to indicate their intention to participate
New York Heart Association Class IV
Myocardial infarction within previous 3 months
Cerebral vascular accident with previous 3 months
Connective tissue disease (e.g. Marfans and Ehlers-Danlos syndrome)
History of bleeding diathesis (including a DIC score > 6, caused by aneurysm, without palliative therapy), coagulopathy or refusal to get blood transfusions
Sensitivity or allergy to stainless steel, ePTFE, PVDF, contrast media or heparin
Unclear cerebellar arteries or Circle of Willis, requiring a stent-graft repair of the sub-clavian artery but without prior bilateral sub-clavian artery bypass
No planned blockage of the LSA, with a <10-mm proximal LZ from the LSA to the aneurysm
No planned blockage of the left carotid artery, with a <10-mm proximal LZ from the left carotid artery to the aneurysm
No planned blockage of the brachiocephalic trunk, with <10 mm proximal LZ from the brachiocephalic trunk to the aneurysm
Planned blockage of the celiac trunk, with an unclear connection between the SMA to the celiac trunk via the pancreaticoduodenal arcade
Planned blockage of the celiac trunk, with a <15-mm proximal LZ from the SMA to the aneurysm
No planned blockage of the celiac trunk, with a <15-mm proximal LZ from the celiac trunk to the aneurysm
Unfavourable access route with calcification, stenosis and tortuous iliac
Unfavourable LZ with calcification, mural haematoma and atheroma
Significant formation of atheroma in the access route, with risk of atherothrombosis
Thoracic aneurysm with a contained rupture
Aortic diameter of <18 or >43 mm in the proximal LZ
Active systemic infection

LZ: landing zone; SMA: superior mesenteric artery; DIC: disseminated intravascular coagulation; ePTFE: expanded polytetrafluoroethylene; PVDF: polyvinylidene fluoride.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close